Datron AG (DAR)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 10.20 |
|---|---|
| 52-week range | 6.90 – 10.40 |
| Return, 1 month / 3 months | +18.6% / +25.2% |
| Return, 1 year / 3 years | +33.3% / +12.2% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 33.8% |
| Worst drawdown (1 year) | -22.9% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Datron AG is a German manufacturer of computer-controlled milling machines, engraving machines and dispensing systems used for machining metal, plastics and other materials. Its customers include industrial firms, workshops and laboratories that need compact, high-speed machining equipment, and the company also supplies cutting tools and automation components. Datron is based in Mühltal, near Darmstadt, and serves customers in Germany and abroad through its own sales and service organisation.
On this site Datron AG appears as a stock on the XETRA Stock Exchange (Germany), code DAR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Datron AG (DAR) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 10.20 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 149 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.3% and over the last three months it rose 25.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 27.1% | ||
| From 52-week high | 0.0% | ||
| Momentum | 84 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 25.2% | ||
| 6-month return | 39.7% | ||
| 12-month return, skipping the last month | 12.4% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.9% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 15.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +18.6% |
| 3 months | +25.2% |
| 6 months | +39.7% |
| 1 year | +33.3% |
| 3 years | +12.2% |
| 5 years | −9.8% |
Signals
| 50-day / 200-day average | 8.92 / 8.02 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | EUR 0.1000 |
| 30 Jun 2025 | EUR 0.1200 |
| 1 Jul 2024 | EUR 0.2000 |
| 3 Jul 2023 | EUR 0.2000 |
| 27 Jun 2022 | EUR 0.2000 |
| 28 Jun 2021 | EUR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.